Your browser is no longer supported. Please, upgrade your browser.
Settings
CDNA CareDx, Inc daily Stock Chart
CDNA [NASD]
CareDx, Inc
Index- P/E125.16 EPS (ttm)0.22 Insider Own4.60% Shs Outstand43.10M Perf Week-0.40%
Market Cap1.19B Forward P/E212.77 EPS next Y0.13 Insider Trans-15.48% Shs Float37.24M Perf Month8.00%
Income-2.20M PEG6.26 EPS next Q-0.01 Inst Own79.40% Short Float6.03% Perf Quarter8.90%
Sales65.60M P/S18.17 EPS this Y130.50% Inst Trans15.94% Short Ratio3.19 Perf Half Y84.28%
Book/sh1.19 P/B23.24 EPS next Y172.20% ROA-89.50% Target Price36.50 Perf Year295.14%
Cash/sh0.61 P/C45.50 EPS next 5Y20.00% ROE-296.90% 52W Range4.92 - 30.80 Perf YTD276.84%
Dividend- P/FCF- EPS past 5Y16.50% ROI193.20% 52W High-10.19% Beta1.07
Dividend %- Quick Ratio2.40 Sales past 5Y18.80% Gross Margin57.20% 52W Low462.20% ATR2.18
Employees55 Current Ratio2.70 Sales Q/Q73.80% Oper. Margin-26.60% RSI (14)53.03 Volatility7.81% 8.59%
OptionableYes Debt/Eq0.31 EPS Q/Q15.10% Profit Margin- Rel Volume0.71 Prev Close27.42
ShortableYes LT Debt/Eq0.30 EarningsNov 08 AMC Payout- Avg Volume703.78K Price27.66
Recom2.00 SMA200.26% SMA506.14% SMA20064.69% Volume496,320 Change0.88%
Oct-23-18Resumed Raymond James Strong Buy $30
Sep-18-18Reiterated H.C. Wainwright Neutral $17 → $22
Nov-27-17Initiated H.C. Wainwright Buy $12
Jun-14-16Reiterated Mizuho Buy $12 → $8
Sep-29-15Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15Initiated Craig Hallum Buy
Mar-18-15Reiterated Mizuho Buy $15 → $12
Nov-28-18 08:25AM  New Research: Key Drivers of Growth for Mersana Therapeutics, Maiden, Payment Data, CareDx, Natera, and Spero Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Nov-26-18 04:01PM  CareDx Strengthens Executive Leadership Team with the Appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer GlobeNewswire
11:25AM  What Kind Of Shareholder Appears On The CareDx Incs (NASDAQ:CDNA) Shareholder Register? Simply Wall St.
08:00AM  CareDx Announces Full Repayment of its Outstanding Debt GlobeNewswire
Nov-16-18 04:01PM  CareDx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Nov-15-18 11:27PM  Edited Transcript of CDNA earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +12.50%
Nov-13-18 11:19PM  CareDx Announces Pricing of Public Offering of Common Stock GlobeNewswire -7.41%
04:01PM  CareDx Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-08-18 06:20PM  CareDx (CDNA) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:14PM  CareDx: 3Q Earnings Snapshot Associated Press
04:01PM  CareDx Reports Third Quarter Results GlobeNewswire
Nov-07-18 08:00AM  CareDx to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-01-18 02:46PM  Harry Boxers four stocks to watch this week MarketWatch
11:28AM  CareDx (CDNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-18-18 07:55AM  Market Trends Toward New Normal in LSC Communications, Corindus Vascular Robotics, Sprouts Farmers Market, Luminex, ChromaDex, and CareDx Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-17-18 08:00AM  CareDx to Announce Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire +6.88%
Oct-02-18 08:00AM  CareDx Profiles AlloSeq Suite of NGS Products at ASHI GlobeNewswire -7.91%
Sep-21-18 08:00AM  CareDx to Participate in Upcoming Investor Conference GlobeNewswire
Sep-18-18 11:10AM  CareDx Inc (NASDAQ:CDNA): Are Analysts Optimistic? Simply Wall St.
Sep-17-18 08:00AM  CareDx broadens HeartCare availability GlobeNewswire
Sep-07-18 03:57PM  Stock Market Forecast: More Gains, More Volatility Investor's Business Daily
Aug-27-18 07:45AM  Edited Transcript of CDNA earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-24-18 08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel New Research Emphasizes Economic Growth GlobeNewswire
Aug-15-18 09:00AM  CareDx to Participate in Upcoming Investor Conference GlobeNewswire
Aug-10-18 08:07PM  Here's Why CareDx Jumped 13.5% Today Motley Fool +13.49%
07:38AM  The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss Benzinga
Aug-09-18 07:40PM  CareDX stock soars nearly 20% after earnings MarketWatch
06:00PM  CareDx (CDNA) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:58PM  CareDx: 2Q Earnings Snapshot Associated Press
04:01PM  CareDx Reports Second Quarter Results GlobeNewswire
Jul-16-18 08:00AM  CareDx to Announce Second Quarter 2018 Financial Results on August 9, 2018 GlobeNewswire
Jun-28-18 08:00AM  Flatiron Health CMO/CSO Joins CareDx Board of Directors GlobeNewswire +5.08%
Jun-22-18 02:55PM  Here's Why CareDx Dropped Today Motley Fool -9.45%
Jun-21-18 07:40AM  Free Technical Reports on Myriad Genetics and Three Additional Services Equities ACCESSWIRE
Jun-19-18 09:00AM  CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes GlobeNewswire
08:10AM  New Research: Key Drivers of Growth for New Mountain Finance, Chicago Rivet & Machine, Caseys General Stores, Great Western, Capstead Mortgage, and CareDx Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-05-18 08:00AM  CareDx Promotes Living Donor Transplantation Through Employee Policy GlobeNewswire +11.56%
Jun-01-18 08:00AM  Key CareDx Events Scheduled at American Transplant Congress 2018 GlobeNewswire
May-24-18 08:00AM  CareDx to Hold Press Conference at American Transplant Congress GlobeNewswire
May-17-18 05:34PM  Edited Transcript of CDNA earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-15-18 12:02PM  Best Growth Stocks To Buy Now Simply Wall St.
May-10-18 05:31PM  CareDx: 1Q Earnings Snapshot Associated Press
04:01PM  CareDx Reports First Quarter Results GlobeNewswire
May-09-18 08:00AM  CareDx expands NGS Transplant Product Offerings GlobeNewswire
May-01-18 08:00AM  CareDx Activities at American Transplant Congress GlobeNewswire +5.11%
Apr-25-18 07:40AM  Free Post Earnings Research Report: CareDxs Quarterly Sales Rose 15%; Adjusted Net Loss Narrowed ACCESSWIRE
Apr-20-18 08:00AM  CareDx to Announce First Quarter 2018 Financial Results on May 10, 2018 GlobeNewswire
Apr-18-18 08:00AM  CareDx Closes Debt Refinancing GlobeNewswire
Apr-13-18 08:00AM  Olerup QTYPE® Receives CE Mark Certification GlobeNewswire
Apr-10-18 08:00AM  CareDx Launches HeartCare® for Heart Transplant Recipients GlobeNewswire
Apr-04-18 07:00AM  Wired News Myriad Genetics Receives Japanese Regulatory Approval for BRACAnalysis(R) Diagnostic System ACCESSWIRE +6.12%
Mar-29-18 08:00AM  CareDx Announces Completion of Debt Conversion GlobeNewswire
Mar-23-18 07:11PM  Edited Transcript of CDNA earnings conference call or presentation 22-Mar-18 8:30pm GMT Thomson Reuters StreetEvents +25.75%
Mar-22-18 04:42PM  CareDx reports 4Q loss Associated Press
04:01PM  CareDx Reports Fourth Quarter and FY2017 Financial Results GlobeNewswire
12:00PM  CareDx, Inc. to Host Earnings Call ACCESSWIRE
Mar-06-18 08:00AM  CareDx to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on March 22, 2018 GlobeNewswire
Mar-01-18 07:30AM  CareDx to Refinance Debt with Perceptive Advisors GlobeNewswire
Feb-27-18 08:25AM  Analysis: Positioning to Benefit within AZZ, Brink's, CareDx, Kinsale Capital Group, Wingstop, and Ambac Financial Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-07-18 08:00AM  CareDx to Participate in Upcoming Investor Conferences GlobeNewswire
Feb-05-18 09:00AM  CareDx Leadership in cfDNA Highlighted at CEoT GlobeNewswire
Feb-01-18 08:00AM  First Patient Enrolled in AlloSure Registry GlobeNewswire
Jan-16-18 09:00AM  TRIO Honors Peter Maag with Transplant Innovation Award GlobeNewswire -8.02%
Jan-08-18 08:30AM  CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results GlobeNewswire
Dec-29-17 10:44AM  CORRECTING and REPLACING - Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Dec-28-17 12:04PM  CORRECTING and REPLACING - Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
08:00AM  Market Trends Toward New Normal in MDU Resources Group, TerraForm Global, CareDx, Kinsale Capital Group, UMB Financial, and Greif Bros. Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Dec-11-17 10:13AM  Here's Why You Should Steer Clear of LifePoint (LPNT) Stock Zacks
Dec-07-17 09:26AM  The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy Zacks
Dec-06-17 01:07PM  4 Attractive Stocks to Buy in an Evolving Healthcare Space Zacks
Dec-01-17 09:02AM  The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx Zacks
Nov-30-17 02:54PM  4 Top-Ranked Growth Stocks in MedTech Under $20 Zacks
Nov-27-17 12:38PM  ETFs with exposure to CareDx, Inc. : November 27, 2017 Capital Cube +10.00%
Nov-20-17 08:00AM  CMS Releases 2018 Clinical Laboratory Fee Schedule GlobeNewswire
Nov-17-17 11:33AM  ETFs with exposure to CareDx, Inc. : November 17, 2017 Capital Cube
Nov-16-17 12:31AM  Edited Transcript of CDNA earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-15-17 09:00AM  CareDx Further Simplifies its Balance Sheet GlobeNewswire
08:49AM  Teladoc Rides on Growing Demand for Telehealth Services Zacks
Nov-13-17 09:21AM  CareDx, Inc. :CDNA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017 Capital Cube
Nov-09-17 04:16PM  CareDx reports 3Q loss Associated Press
04:02PM  CareDx Reports Third Quarter 2017 Financial Results GlobeNewswire
12:30PM  CareDx, Inc. to Host Earnings Call ACCESSWIRE
Nov-07-17 09:54AM  ETFs with exposure to CareDx, Inc. : November 7, 2017 Capital Cube
Nov-02-17 09:00AM  CareDx to Participate in Upcoming Investor Conferences GlobeNewswire
Oct-31-17 09:00AM  CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Oct-30-17 08:00AM  AlloSure data will be presented at ASN GlobeNewswire
Oct-27-17 09:00AM  CareDx to Announce Third Quarter 2017 Financial Results on November 9, 2017 GlobeNewswire
Oct-10-17 04:00PM  CareDx Announces Closing of Public Offering of Common Stock GlobeNewswire
11:08AM  ETFs with exposure to CareDx, Inc. : October 10, 2017 Capital Cube
Oct-05-17 07:45PM  How Does CareDx Inc (CDNA) Affect Your Portfolio Returns? Simply Wall St. +31.97%
Sep-26-17 08:30AM  MolDX sets AlloSure reimbursement at 2017 AlloMap level GlobeNewswire +23.72%
Sep-25-17 10:35AM  ETFs with exposure to CareDx, Inc. : September 25, 2017 Capital Cube +8.12%
Sep-22-17 05:26PM  AlloMaps Medicare reimbursement to increase in 2018 GlobeNewswire
Sep-21-17 06:51PM  Have Investors Already Priced In CareDx Incs (CDNA) Growth? Simply Wall St.
01:41PM  This Market Knows No Fear TheStreet.com
Sep-14-17 06:04PM  ETFs with exposure to CareDx, Inc. : September 14, 2017 Capital Cube
Sep-13-17 11:28AM  CareDx, Inc. :CDNA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017 Capital Cube
Aug-24-17 01:05PM  CareDx Confirms AlloSure Will Receive Medicare Coverage Effective October 9th, 2017 GlobeNewswire +33.02%
Aug-17-17 07:50AM  Edited Transcript of CDNA earnings conference call or presentation 10-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-15-17 08:00AM  CareDx to Participate in Upcoming Investor Conferences GlobeNewswire +5.26%
CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, engages in the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients worldwide. It operates through two segments, Post-Transplant Diagnostics and Pre-Transplant Diagnostics. The Post-Transplant Diagnostics segment develops and provides a diagnostic surveillance testing solution for heart and kidney transplant recipients. It offers AlloMap, a heart transplant molecular test; and AlloSure, a donor-derived cell free DNA test initially used for kidney transplant patients. The Pre-Transplant Diagnostics segment develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and organs. It sells Olerup SSP, which is used to type human leukocyte antigen (HAL) alleles based on sequence-specific primer technology; Olerup QTYPE, a test kit for sequence based HLA typing; Olerup SBT, a test kit for sequence based HLA typing; and XM-ONE, a test that identifies a patient's antigens against HLA Class I or Class II, as well as antibodies against a donor's endothelium. This segment offers its products directly to customers, as well as through third-party distributors. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maag PeterSee RemarksNov 29Sale28.597,831223,898400,541Nov 30 09:38 PM
Maag PeterSee RemarksNov 28Sale28.5292,1692,628,614408,372Nov 30 09:38 PM
Maag PeterSee RemarksNov 21Option Exercise3.60110,794398,795500,541Nov 21 05:37 PM
Maag PeterSee RemarksNov 13Sale26.4850,0001,323,945389,747Nov 15 09:55 PM
Gagnon Neil10% OwnerOct 31Sale27.05108,5992,937,331107,940Nov 02 04:16 PM
King SashaChief Commercial OfficerOct 05Sale24.6011,500282,90053,542Oct 09 07:23 PM
Bell Michael BrianChief Financial OfficerSep 13Sale25.0616,355409,92052,238Sep 13 08:26 PM
Maag PeterSee RemarksSep 04Sale23.1015,000346,542439,747Sep 04 09:25 PM
Cohen Fred EDirectorAug 28Option Exercise1.2215,00018,30052,901Aug 29 06:09 PM
Bell Michael BrianChief Financial OfficerAug 14Sale16.8412,500210,46368,593Aug 14 04:41 PM
King SashaChief Commercial OfficerAug 01Option Exercise1.036,4586,64874,500Aug 01 07:32 PM
King SashaChief Commercial OfficerAug 01Sale14.039,458132,73565,042Aug 01 07:32 PM
Nelles Mitchell JChief Operating OfficerJul 02Option Exercise4.2531,899135,649126,538Jul 03 05:43 PM
Nelles Mitchell JChief Operating OfficerJul 02Sale12.4839,649494,91186,889Jul 03 05:43 PM
GAGNON NEIL10% OwnerApr 26Buy9.4210,13695,481965,894Apr 30 05:48 PM
Maag PeterSee RemarksMar 27Sale7.8715,000118,035272,037Mar 28 04:46 PM
Maag PeterSee RemarksMar 20Option Exercise0.5550,00027,400287,037Mar 21 06:00 PM